MarketsNotableConfirmedDeveloping
6.5
Banco do Brasil CEO faces CVM sanctioning process over stock recommendation
Brazil Journal·BR·2 days ago
MarketsConfirmedMediumDeveloping
5.9
Centaurus Capital mandated to launch tender offer for Oncoclínicas by October 24
Centaurus Capital must initiate a tender offer for Oncoclínicas (ONCO3) shares by October 24, 2026, following a regulatory trigger from the CVM. The offer price will be indexed to the Selic rate, reflecting a mandatory acquisition process under Brazilian securities law.
Score Breakdown
Mosaic Score5.9
Confidence0.9
Significance0.5
Source credibility0.5
Related signals
8 foundMarketsNotableSingle-sourceDeveloping
5.4
Brazil CVM approves R$ 6.5 billion tender offer for Oncoclínicas
Valor Econômico·BR·3 days ago
MarketsNotableEmergingDeveloping
5.4
Oncoclínicas tender offer valuation estimated at R$ 11.7 billion
Valor Econômico·BR·about 23 hours ago
MarketsNotableConfirmed
6.9
Brazil records $1.689 billion net inflow into equity markets in July
InfoMoney·BR·about 23 hours ago
MarketsNotableConfirmed
6.9
Ibovespa gains 1.61% as BRL strengthens to 5.14 per USD
Poder360·BR · US·3 days ago
MarketsNotableConfirmed
6.4
Morgan Stanley shifts to defensive stance on Brazilian equities citing 2027 outlook
InfoMoney·BR · FK·2 days ago
MarketsNotableConfirmedDeveloping
6.4
Foreign capital outflows from Brazilian equities reach R$ 21.37 billion in August 2026
InfoMoney·BR·2 days ago
MarketsNotableConfirmed
6.4
Squadra Investimentos reduces Hapvida stake, citing significant capital loss
InfoMoney·BR·3 days ago